The Prevalence and Outcome of Acute Hypoxemic Respiratory Failure (PANDORA) Study in Mechanically Ventilated

Yolanda M López-Fernández1, Amelia Martínez-de-Azagra2, Susana B Reyes-Domínguez3

  • 1Pediatric Intensive Care Unit, Department of Pediatrics, Cruces University Hospital, Biocruces-Bizkaia Health Research Institute, Bizkaia, Spain.

Insights

Pediatric acute respiratory distress syndrome (PARDS) affects over half of children with acute hypoxemic respiratory failure (AHRF) requiring invasive mechanical ventilation. PARDS significantly increases mortality risk in these critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Physiology
  • Epidemiology

Background:

  • Acute hypoxemic respiratory failure (AHRF) and pediatric acute respiratory distress syndrome (PARDS) are critical conditions in children.
  • Understanding the epidemiology and outcomes of AHRF and PARDS is crucial for improving patient care.

Purpose of the Study:

  • To determine the prevalence of AHRF and PARDS in children requiring invasive mechanical ventilation (IMV).
  • To describe the outcomes, including mortality rates, associated with AHRF and PARDS in a pediatric intensive care unit (PICU) population.

Main Methods:

  • A prospective, observational study was conducted across 22 PICUs in Spain from October 2019 to September 2021.
  • Consecutive children aged 7 days to 15 years diagnosed with AHRF (PaO2/FiO2 ≤ 300 mmHg) requiring IMV with specific PEEP and FiO2 settings were included.
  • Data on AHRF prevalence, IMV-PARDS prevalence, and adjunctive therapy use were collected. Outcomes included PICU mortality and ventilator-free days.

Main Results:

  • AHRF was diagnosed in 2.8% of PICU admissions requiring IMV.
  • Of those with AHRF, 50.3% met the criteria for PARDS.
  • PICU mortality was significantly higher in patients with PARDS (30.8%) compared to those with AHRF without PARDS (14.4%). Patients with PARDS also had fewer ventilator-free days.

Conclusions:

  • The prevalence of AHRF in this pediatric intensive care population is significant, with PARDS being a common complication.
  • PARDS is associated with a substantially increased risk of mortality in children with AHRF.
  • These findings highlight the severity of PARDS and the need for effective management strategies in pediatric critical care.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
129
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
151
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
962
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
107
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
145
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
107